Download PDF
Thromb Haemost 1975; 33(01): 087-096
DOI: 10.1055/s-0038-1647816
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

Low Dose Heparin in the Prevention of Venons Thromboembolism[*]

Rationale and Results
V. V Kakkar
1   Department of Surgery, King’s College Hospital, Medical School, Denmark Hill, London SE 5 8 RX
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Ballard R. M. Low dose of subcutaneous heparin in the prevention of deep venous thrombosis after gynaecological surgery. Journal of Obstetrics and Gynaecology of the British Commonwealth 1973; 80: 469
    CrossrefPubMedGoogle Scholar
  • 2 Bauer G. Thirteen years’ experience with heparin therapy. In Koller Th, Merz W. R. (Eds.) Proceedings of the First International Conference on Thrombosis and Embolism. Schwabe Verlag, Basel p. 721 1954;
    PubMedGoogle Scholar
  • 3 Blombäck B, Blombäck M, Hessel B, Iwanaga S. Structure of N- terminal fragments of fibrinogen and specificity of thrombin. Nature 1967; 215: 1445
    CrossrefPubMedGoogle Scholar
  • 4 Brinkhous K, Smith H. P, Warner E. D, Seegers W. H. The inhibition of blood clotting. An unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. American Journal of Physiology 1939; 125: 683
    PubMedGoogle Scholar
  • 5 Corrigan T. P, Kakkar V. V, Fossard D. P. Low doses subcutaneous heparin - optimal dose regimen. British Journal of Surgery 1974; 61: 320
    PubMedGoogle Scholar
  • 6 Dechavanne M, Ville D, Viala J. J, Kher A, Faivre J. et al. A controlled trial of heparin, aspirin and dipyridamole in prevention of deep vein thrombosis in patients undergoing total hip replacement. Personal communication. 1974
    PubMedGoogle Scholar
  • 7 De Takats G. Anticoagulants in surgery. Journal of the American Medical Association 1950; 142: 527
    CrossrefPubMedGoogle Scholar
  • 8 Edinburgh Hospitals Trials (multiple authors) Heparin versus dextran in the prevention of od deep-vein thrombosis – A multi-unit controlled trial. Lancet 1974 2. 118
    PubMedGoogle Scholar
  • 9 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis haemorrhagica 1965; 14: 473
    PubMedGoogle Scholar
  • 10 Gallus A. S, Hirsh J, Tuttle R. J, Trebilcock R, O’Brien S. E. The use of small doses of heparin to prevent venous thrombosis in surgical and medical patients. New England Journal of Medicine 1973; 288: 545
    CrossrefPubMedGoogle Scholar
  • 11 Gordon-Smith I. C, Grundy D. J, Le Quesne L. P, Newcombe J. F, Bramble F. S. Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep vein thrombosis. A double blind randomized trial. Lancet 1972; 1: 1133
    PubMedGoogle Scholar
  • 12 Griffith J. C, Boggs R. B. The clinical use of heparin. American Journal of Cardiology 1964; 39: 14
    PubMedGoogle Scholar
  • 13 Han P, Ardlie N. G. Heparin, platelets and blood coagulation: Implication for low-dose heparin prophylactic regimens in venous thrombosis. British Journal of Haematology 27 1974; 253
    CrossrefPubMedGoogle Scholar
  • 14 Hume M, Sevitt S, Thomas D. P. Venous thrombosis and pulmonary embolism. Harvard University Press; Cambridge, Mass.: p. 3 1970
    Google Scholar
  • 15 Hume M, Kuriakose T. X, Zuch L, Turner R. H. 125I-fibrinogen and the prevention of venous thrombosis. Archives of Surgery 1973; 107: 803
    CrossrefPubMedGoogle Scholar
  • 16 Kakkar V. V. Low doses of heparin in the prevention of deep vein thrombosis. Bulletin of the Swiss Academy of Medical Sciences 1973; 29: 235
    PubMedGoogle Scholar
  • 17 Kakkar V. V. Unpublished observations 1974
    PubMed
  • 18 Kakkar V. V, Howe C. T, Laws J. W, Flanc C. Late results of treatment of deep vein thrombosis. British Medical Journal 1: 810 1969; a
    PubMedGoogle Scholar
  • 19 Kakkar V. V, Howe C. T, Flanc C, Clarke M. B. The natural history of postoperative deep vein thrombosis. Lancet 2: 230 1969; b
    PubMedGoogle Scholar
  • 20 Kakkar V. V, Field E. S, Nicolaides A. N, Flute P. T, Wessler S, Yin E. T. Low doses of heparin in the prevention of deep vein thrombosis. Lancet 1971; 2: 699
    PubMedGoogle Scholar
  • 21 Kakkar V. V, Corrigan T. P, Spindler J, Fossard D. P, Flute P. T, Crellin R. Q, Wessler S, Yin E. T. Efficacy of low doses of heparin in prevention of deep vein thrombosis after major surgery. A double-blind randomized trial. Lancet 1972; 2: 101
    PubMedGoogle Scholar
  • 22 Lenggenhager K. Genese and Prophylaxis der postoperativen Fernthrombose. Helvetica Chirurgica Acta 1957; 24: 316
    PubMedGoogle Scholar
  • 23 Monkhouse F. C, France E. S, Seegers W. H. Studies on the antithrombin and heparin co-factor activities of a fraction absorbed from plasma by aluminium hydroxide. Circulation Research 1955; 3: 397
    CrossrefPubMedGoogle Scholar
  • 24 Morrell M. T, Truelove S. C, Barr A. Deep vein thrombosis and pulmonary embolism. British Medical Journal 1963; 2: 850
    PubMedGoogle Scholar
  • 25 Nicolaides A. N, Dupont P. A, Desai S, Lewis J. D, Douglas J. N, Dodsworth H, Fourides G, Luck R. J, Jamieson C. W. Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 1972; 2: 890
    PubMedGoogle Scholar
  • 26 Nicolaides A. N, Dupont P, Parsons D, Appleburg M, Horan F. T, Esah K. M, Walker C. J. Small doses subcutaneous sodium heparin in preventing deep venous thrombosis after elective hip surgery. British Journal of Surgery 1974; 61: 320
    PubMedGoogle Scholar
  • 27 O’Brien J. R, Jamieson S, Etherington M, Klaber M. R. Platelet function in venous thrombosis and low dosage heparin. Lancet 1972; 1: 1301
    PubMedGoogle Scholar
  • 28 Porter P, Porter M. C, Shanberge J. N. Interaction of heparin with the plasma protein in relation to its anti-thrombin activity. Biochemistry 1967; 6: 1854
    CrossrefPubMedGoogle Scholar
  • 29 Rosenberg R. D, Damus D. S. The purification and mechanism of action of human anti-thrombin heparin co-factor. Journal of Biological Chemistry 1973; 248: 6490
    PubMedGoogle Scholar
  • 30 Sharnoff J. G, De Blasio G. Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 1970; 2: 1006
    PubMedGoogle Scholar
  • 31 Sharnoff J. G, Kass H. H, Mistica B. A. A plasma heparinization of the surgical patients to prevent postoperative thrombo-embolism. Surgery, Gynecology and Obstetrics 1962; 115: 75
    PubMedGoogle Scholar
  • 32 Sharnoff J. G, Bagg J. F, Breen S. R, Rogliano A. S, Walsh A. R, Scardino V. The possible indication of postoperative thrombo-embolism by platelet counts and blood coagulation studies in the patients undergoing extensive surgery. Surgery, Gynecology and Obstetrics 1960; 111: 469
    PubMedGoogle Scholar
  • 33 Van Vroonhoven T. J. M. V, Van Ziji J, Muller H. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep venous thrombosis. A controlled clinical trial. Lancet 1974; 1: 375
    PubMedGoogle Scholar
  • 34 Wessler S. The theory and practice of mini-dose heparin in surgical patients: A status report. Circulation 1973; 47: 661
    PubMedGoogle Scholar
  • 35 Williams H. T. Prevention of postoperative deep vein thrombosis with perioperative sucutaneous heparin. Lancet 1971; 2: 950
    PubMedGoogle Scholar
  • 36 Yin E. T, Wessler S. Evidence for a naturally occuring plasma inhibitor of activated factor X: its isolation and partial purification. Thrombosis et Diathesis haemorrhagica 1969; 21: 398
    PubMedGoogle Scholar
  • 37 Yin E. T, Wessler S, Stoll P. Identity of plasma-activated factor X inhibitor with antithrombin III and heparin co-factor. Journal of Biological Chemistry 1971; 246: 3712
    PubMedGoogle Scholar